1. A second locus for Aicardi-Goutières syndrome at chromosome 13q14–21. Issue 5 (20th May 2005) Authors: Ali, M; Highet, L J; Lacombe, D; Goizet, C; King, M D; Tacke, U; van der Knaap, M S; Lagae, L; Rittey, C; Brunner, H G; van Bokhoven, H; Hamel, B; Oade, Y A; Sanchis, A; Desguerre, I; Cau, D; Mathieu, N; Moutard, M L; Lebon, P; Kumar, D Journal: Journal of medical genetics Issue: Volume 43:Issue 5(2006) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP050 Influence of disease location on vedolizumab efficacy in inflammatory bowel disease: a real-life multicentre experience. (16th January 2018) Authors: Pestour, S; Nancey, S; Charlois, A L; Bonaz, B; Flourie, B; Boschetti, G; Mathieu, N Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent. (21st January 2022) Authors: Buisson, A; Nachury, M; Fumery, M; Guilmoteau, T; Leclerc, E; Altwegg, R; Serrero, M; Mathieu, N; Treton, X; Vuitton, L; Pereira, B; Amiot, A; Bouguen, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is propofol a safe and effective sedative for relocating hip prostheses?. Issue 1 (22nd December 2008) Authors: Mathieu, N; Jones, L; Harris, A; Hudson, A; McLauchlan, C; Riou, P; Lloyd, G Journal: Emergency medicine journal Issue: Volume 26:Issue 1(2009) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐Term Therapy With Bevacizumab in a Patient With Glanzmann's Thrombasthenia and Recurrent Digestive Bleeding due to Gastrointestinal Angiodysplastic Lesions. (February 2015) Authors: Marlu, Raphael; Barthelon, J; Durand, A; Mathieu, N; Barro, C; Granger, V; Tatu, A; Pernod, G; Polack, B; Bonaz, B Journal: American journal of gastroenterology Issue: Volume 110:Number 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P045 Local administration of extracellular vesicles from adipose-derived stromal cells promote healing in a rat model of radiation colitis – a pilot study. (30th January 2023) Authors: Sebbagh, A; Mathieu, N; Demarquay, C; Geiger, M; Sémont, A; Simon, C; Branchu, J; Milliat, F; Gazeau, F; Wilhelm, C; Silva Brun, A; Rahmi, G Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P144 Impact of major medication discontinuation during the first wave of COVID-19 pandemic on the risk of early relapse in patients with inflammatory bowel disease: a French observational retrospective study. (30th January 2023) Authors: Meunier, C; Monte, C; Hadjisavvas, H; Rozieres, A; Roblin, X; Venturin, C; Gay, C; Flourie, B; Boschetti, G; Danion, P; Mathieu, N; Charlois, A L; Faure, M; Nancey, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P404 Persistence of subcutaneous infliximab after switching from intravenous in a French national cohort of IBD patients in remission. (30th January 2023) Authors: Mathieu, N; Riviere, P; Heluwaert, F; Hébuterne, X; Chupin, A; Bouguen, G; Vuitton, L; Allez, M; Montuclard, C; Nachury, M; Nancey, S; Amélie, B; Gilletta, C; Abitbol, V; Altwegg, R; de Maissin, A; Plastaras, L; Ah Soune, P; Boureille, A; Bouhnik, Y Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P494 Impact of early optimization of ustekinumab on mid-term targets in severe Crohn's disease: THE MUST study. (30th January 2023) Authors: Abdelmoula, A; Chateau, T; Hupe, M; Boschetti, G; Roblin, X; Nancey, S; Mathieu, N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P507 What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?. (16th January 2018) Authors: Lefebvre, T; Cormons, R; Faucheron, J -L; Baudrant, M; Bonaz, B; Mathieu, N Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗